Overcoming Dissolution Challenges with Low-Dose Pharmaceuticals and Medical Devices
Novel dosage forms require novel dissolution techniques and instruments. Drug-eluting stent testing, transdermals, implants, contact lenses, medical devices, and a variety of other products require absolute control over evaporative losses and assurance of analytical sample integrity. The dissolution testing is frequently done using ultralow volumes in the 5–10 mL range.
In this webinar, we will explore tools and techniques that address the challenges of these types of analysis by examining several examples and case studies.
Key learning objectives
- Discover dissolution techniques for novel formulations
- Explore case studies for small-volume dissolution testing
- Learn about the Agilent 400-DS
Who should attend?
- Dissolution users, lab managers in R&D and QC, and drug/device manufacturers
Presenter: Dr. Karen Krauel-Goellner (Product Manager Dissolution Systems, Agilent Technologies)
Dr. Karen Krauel-Goellner is a registered pharmacist and holds a PhD from the University of Otago, NZ, in the area of formulation development. Krauel-Goellner previously held research positions at universities and Boehringer Ingelheim, and worked as a clinical supply manager at Boehringer Ingelheim Vetmedica. In 2013, Krauel-Goellner joined Agilent Technologies and is currently a Global Product Manager for Agilent Dissolution Systems.
Presenter: Georgina Wynne Hughes (Editorial Team, SelectScience)
Georgina studied at Birmingham University where she gained a BSc in Biomedical Science, and an MSc by Research in Cancer and Genomic Sciences, which focused on defective autophagy in rare neurodegenerative diseases. As a member of the Editorial team, she now plays an integral role in shaping the content on SelectScience.
